Reports

Drug name	NICE TAs	Comments
Mobocertinib (Exkivity®)	TA855 - Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy
Mogamulizumab (Poteligeo®)	TA754 - Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome
Mometasone furoate 0.1% cream	TA81 - Frequency of application of topical corticosteroids for atopic eczema
Mometasone furoate 0.1% ointment	TA81 - Frequency of application of topical corticosteroids for atopic eczema
Mycophenolate mofetil capsules	TA85 - Immunosuppressive therapy for renal transplantation in adults
Mycophenolate mofetil injection	TA85 - Immunosuppressive therapy for renal transplantation in adults
Mycophenolate mofetil suspension	TA85 - Immunosuppressive therapy for renal transplantation in adults	New post-transplant
Mycophenolate mofetil suspension#amber	TA85 - Immunosuppressive therapy for renal transplantation in adults	Post-transplant pre 2013
Naldemedine (Rizmoic®)	TA651 - Naldemedine for treating opioid-induced constipation
Nalmefene	TA325 - Nalmefene for reducing alcohol consumption in people with alcohol dependence	Restricted to specialist substance misuse services

University Hospitals Birmingham NHS Foundation Trust